sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Gene Therapy Market Trends and Growth Insights 2025-2031

Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Vectors (Non-Viral Vectors and Viral Vectors), Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, and Other Indications), Delivery Mode (In-Vivo and Ex-Vivo)

  • Report Date : Oct 2025
  • Report Code : TIPHE100001165
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 300

The Gene Therapy Market size is projected to reach US$ 12.92 billion by 2031 from US$ 5.06 billion in 2024. The market is expected to register a CAGR of 14.50% during 2025–2031.

Gene Therapy Market Analysis

The rise in chronic and genetic disease prevalence, increasing advancements in genetic engineering technologies, supportive regulatory frameworks, and increased research and development investments favor the growth of the gene therapy market. Integrating artificial intelligence (AI) into personalized medicine contributes to market development. Opportunities lie in emerging economies where disease prevalence and healthcare infrastructure are improving.

Gene Therapy Market Overview

Gene therapy is a medical approach that treats diseases by either inactivating a faulty gene, replacing it with a healthy copy, or introducing a new or modified gene into the body to help treat or prevent the condition. It can be classified into in vivo and ex vivo gene therapy. Gene therapy is used to cure cancers, neurological disorders, cardiovascular disease, infectious diseases, and rare diseases. Gene therapy encompasses the manipulation of genes to fight or prevent diseases. The therapy works by introducing a functional gene into individuals affected by a disease caused by a defective or mutated gene. Among the treatments are biosimilars, vaccines, complex generics, gene therapies, immuno-therapies, and novel drugs.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Gene Therapy Market: Strategic Insights

gene-therapy-market
Market Size Value inUS$ 5.11 billion in 2023
Market Size Value byUS$ 25.69 billion by 2031
Growth rateCAGR of 14.3% from 2023 to 2031
Forecast Period2023-2031
Base Year2023
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst
Gene Therapy Market Drivers and Opportunities

Market Drivers:

  • Growing Prevalence Of Genetic Diseases And Cancer:

    In the US, ~ 25 to 30 million individuals suffer from rare diseases, many of which are genetic and suitable for gene therapy.

  • Advancements in Genetic Engineering Technologies:

    Recent innovations in genetic engineering technologies, such as CRISPR/Cas9, base editing, and enhanced viral vectors, accelerate the development and application of therapies.

  • Supportive Government Initiatives:

    From 2024 to 2025, the FDA has expedite the approval process for cell and gene therapies, focusing on innovation and ongoing monitoring.

  • Expanding Healthcare Infrastructure:

    Research and development investments have surged, with global funding reaching billions due to public-private partnerships and grants, which have enabled over 3,000 clinical trials worldwide.

  • Expansion of Gene Therapy CDMOs:

    RoslinCT and Lykan Bioscience, prominent CDMOs in the cell and gene therapy industry, have formed a unified company operating under the RoslinCT brand.

Market Opportunities:

  • Expansion into Emerging Markets:

    Adoption of advanced gene editing technologies, such as CRISPR and gene delivery systems, enable more effective and precise treatments. As these innovations become more accessible, they pave the way for gene therapies to address unmet medical needs, making treatment options smarter, more reliable, and more cost-effective.

  • Personalised Medicine:

    Developing treatment that can be customized for different genetic profiles supports approaches in precision medicine. Healthcare professionals can optimize treatments, cut down on wasteful spending, and make it simpler to upgrade therapeutic protocols by attending to the needs of each individual patient.

  • R&D Activities by the Market Players:

    Investing in research for gene therapy techniques that utilize non-viral delivery methods, improve safety profiles, and enhance patient outcomes provides a competitive advantage.

  • Emerging Applications Such as Autoimmune and Solid Tumor Treatment:

    The increasing demand for innovative treatments in fields such as oncology, rare genetic disorders, and chronic diseases drives growth in the gene therapy market.

Gene Therapy Market Report Segmentation Analysis

The gene therapy market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest gene therapy market trends. Below is the standard segmentation approach used in industry reports:

By Vectors:

  • Non-Viral Vectors:

    The increasing preference for non-viral vectors is influencing the dynamics of the gene therapy market by broadening its therapeutic potential.

  • Viral Vectors:

    Viral vectors derived from adeno-associated viruses (AAV), lentiviruses, adenoviruses, and retroviruses constitute the backbone of FDA-approved gene therapies.

By Indication:

  • Neurological Diseases:

    The development of gene therapies offers potential one-time cures rather than lifelong symptom management of conditions such as neurodegenerative diseases and spinal muscular atrophy (SMA).

  • Cancer:

    The rising prevalence of cancer is increasing the demand for advanced, targeted treatments like gene therapies.

  • Duchenne Muscular Dystrophy:

    The urgency for curative options such as gene therapies, which tackle the root causes, including mutations in the dystrophin gene, rather than merely alleviating symptoms increases as the number of DMD cases grows

  • Hepatological Diseases:

    Rising cases of hepatological diseases have spurred investment in the pharmaceutical sector, with companies accelerating clinical trials and regulatory submissions to seize an expanding market.

  • Other Indications:

    The increasing incidence of rare diseases propels the use of gene therapy techniques, such as antibody-drug conjugates.

By Delivery Mode:

  • In-Vivo
  • Ex-Vivo

By Geography:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Gene Therapy Market Report ScopeGene Therapy Market Share Analysis by Geography

The gene therapy market in Asia Pacific is witnessing the fastest growth. The need for faster order fulfilment, the booming e-commerce ecosystem, and investment in the booming e-commerce ecosystem are factors driving market expansion. Emerging markets in Latin America, the Middle East, and Africa have untapped opportunities for gene therapy providers to expand. The gene therapy market grows differently in each region. Below is a summary of market share and trends by region:

1. North America

  • Market Share:

    Holds a significant portion of the global market

  • Key Drivers:

    The increasing research and development of innovations contribute to the region's growing gene therapy market size. The US FDA has approved 7 cell and gene therapy drugs, with the pipeline of new products reaching ~1,200 experimental therapies. Half of these are in Phase 2 clinical trials, with estimates of annual sales growth accounting for 15% for cell therapies and ~30% for gene therapies, as per the Chemical & Engineering News report 2023 estimates.

  • Trends:

    Adoption of AI in gene editing by market players.

2. Europe

  • Market Share:

    Substantial share due to early adoption of CRISPR/Cas9, base editing, and improved viral vector technologies.

  • Key Drivers:

    The availability of advanced research facilities and the high demand for technologically advanced genetic engineering tools for research and development of gene therapies contribute to the region's market growth.

  • Trends:

    Investments in smart gene editing solutions.

3. Asia Pacific

  • Market Share:

    Region is fastest-growing with increasing market share each year.

  • Key Drivers:

    A strong and supportive research infrastructure and government regulations fuel the adoption of gene therapies. Countries is the region are facing a growing burden of chronic and genetic diseases, escalating the demand for innovative therapies. The rising business expansion strategies by the market players in this region are propelling the gene therapy market share.

  • Trends:

    Increasing investment in gene therapy and collaboration with CDMOs in Asia Pacific.

4. South and Central America

  • Market Share:

    Growing market with steady progress

  • Key Drivers:

    • The increasing prevalence of genetic and rare diseases in the region is creating urgent demand for advanced therapies. Further, the government initiatives for the development of healthcare infrastructure are fueling the adoption. Fiocruz, a research foundation under the Brazilian Ministry of Health, partnered with Caring Cross in March 2024 to establish local production of CAR-T therapies. This collaboration is anticipated to reduce the cost to US$ 35,000 per dose in Brazil.

  • Trends:

    Expanding clinical trials supporting the development of gene therapies.

5. Middle East and Africa

  • Market Share:

    Although small, but growing quickly

  • Key Drivers:

    • Growing investment in infrastructure under government initiatives such as the Emirati Genome Programme is vital in increasing the demand for gene therapies.
    • Robust regulatory approval frameworks supporting the research and development of innovations fuel the growth of the gene therapy market.

  • Trends:

    Public and private partnerships to adopt new gene editing technologies.

Gene Therapy Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

Competition is strong due to the presence of established players such as BEUMER Group GmbH & Co KG and Bastian Solutions LLC. Regional and niche providers such as Orchard Therapeutics (Europe), Passage Bio (US), and Yapan Bio (India) add to the competitive landscape across regions.

This high level of competition urges companies to stand out by offering:

  • Advanced security features
  • Value-added services such as analytics & predictive maintenance, real‑time operational analytics, and installation
  • Competitive pricing models
  • Strong customer support and easy integration

Opportunities and Strategic Moves

  • Manufacturers and CDMOs collaborate to develop new gene therapies with advanced genetic engineering tools.
  • Regulatory bodies such as the US FDA, Canada Health, and ANVISA have streamlined the approval process for the fast and easy launch of innovations.
  • Academic and research institutes are expanding research capabilities with government grants and funds.

Additional companies analyzed during the course of research:

  1. Intellia Therapeutics
  2. Sana Biotechnology
  3. Caribou Biosciences
  4. Editas Medicine
  5. Beam Therapeutics
  6. Sangamo Therapeutics
  7. Freeline
  8. Orchard Therapeutics
  9. uniQure
  10. Pfizer
  11. Takara Bio Inc
  12. PTC Therapeutics
  13. Adaptimmune Therapeutics
  14. Adverum Biotechnologies
  15. Bayer
  16. eGenesis

Gene Therapy Market News and Recent Developments

  • AGC Biologics Launched a New Dedicated Cell and Gene Business Division.

    The new Cell and Gene Technologies Division launched byAGC Biologics will focus on elevating AGC Biologics’ existing capabilities and supporting developers who need capacity, scientific capabilities, and technically qualified cell and gene CDMO operators. The site offers 30 years of experience in cell and gene therapy, with nine commercial approvals and hundreds of GMP batches produced successfully

  • FDA Approved Casgevy and Lyfgenia to Treat Patients with Sickle Cell Disease

    Casgevy is the first FDA-approved therapy utilizing CRISPR/Cas9, a genome editing technology. Patients’ hematopoietic (blood) stem cells are modified by genome editing using CRISPR/Cas9 technology.

Gene Therapy Market Report Coverage and Deliverables

The "Gene Therapy Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

  • Gene Therapy Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Gene Therapy Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PEST and SWOT analysis
  • Gene Therapy Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the gene therapy Market
  • Detailed company profiles
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Vectors, Indication, Delivery Mode, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions

Which are the leading players operating in the gene therapy market?

Novartis AG; Astellas Pharma Inc; Bristol-Myers Squibb Co, Bluebird Bio Inc, PTC Therapeutics, Inc, Sanofi SA, Daiichi Sankyo Co Ltd, CSL Behring LLC, BioMarin Pharmaceutical Inc., and Vertex Pharmaceuticals Inc are among the key players operating in the gene therapy market.

What are the factors driving the gene therapy market?

The rising rare and genetic diseases and advancements in genetic engineering technologies are noteworthy factors contributing to the market growth.

Which region dominated the gene therapy market in 2024?

North America dominated the market in 2024.

What is the expected CAGR of the gene therapy market?

The gene therapy market is estimated to register a CAGR of 14.5% during the forecast period.

What would be the estimated value of the gene therapy market by 2031?

The gene therapy market is estimated to reach US$ 12.92 billion by 2031.

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Analyst Market Outlook

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macro-economic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country level data:

3.3 Assumptions and Limitations

4. Gene Therapy Market Landscape

4.1 Overview

4.2 PEST Analysis

5. Gene Therapy Market – Key Market Dynamics

5.1 Gene Therapy Market – Key Market Dynamics

5.2 Market Drivers

5.2.1 Rising Prevalence of Genetic and Chronic Diseases

5.2.2 Advancements in Genetic Engineering Technologies

5.2.3 Supportive Regulatory Frameworks and Increased Research and Development Investments

5.3 Market Restraints

5.3.1 High Costs and Affordability Issues

5.3.2 Regulatory Hurdles and Funding Barriers

5.3.3 Manufacturing and Scalability Challenges

5.4 Market Opportunities

5.4.1 Expansion into Emerging Markets

5.4.2 Innovations in Cost-Reduction for Manufacturing

5.4.3 Application to Autoimmune and Solid Tumor Treatments

5.5 Future Trends

5.5.1 Integration of Artificial Intelligence

5.5.2 Advancements in In Vivo Delivery and Nucleic Acid Designs

5.5.3 Focus on Non-Coding RNAs and NGS-Based Diagnostics

5.6 Impact of Drivers and Restraints:

6. Gene Therapy Market – Global Market Analysis

6.1 Gene Therapy Market Revenue (US$ Million), 2021–2031

6.2 Gene Therapy Market Forecast Analysis

7. Gene Therapy Market Analysis – by Vector

7.1 Non-Viral Vectors

7.1.1 Overview

7.1.2 Non-Viral Vectors: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Viral Vectors

7.2.1 Overview

7.2.2 Viral Vectors: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8. Gene Therapy Market Analysis – by Indications

8.1 Neurological Diseases

8.1.1 Overview

8.1.2 Neurological Diseases: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8.2 Cancer

8.2.1 Overview

8.2.2 Cancer: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8.3 Duchenne Muscular Dystrophy

8.3.1 Overview

8.3.2 Duchenne Muscular Dystrophy: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8.4 Hepatological Diseases

8.4.1 Overview

8.4.2 Hepatological Diseases: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8.5 Other Indications

8.5.1 Overview

8.5.2 Other Indications: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

9. Gene Therapy Market Analysis – by Delivery Mode

9.1 In-Vivo

9.1.1 Overview

9.1.2 In-Vivo: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

9.2 Ex-Vivo

9.2.1 Overview

9.2.2 Ex-Vivo: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

10. Gene Therapy Market – Geographical Analysis

10.1 Overview

10.2 North America

10.2.1 North America Gene Therapy Market Overview

10.2.2 North America: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)

10.2.3 North America: Gene Therapy Market Breakdown, by Vector

10.2.3.1 North America: Gene Therapy Market – Revenue and Forecast Analysis – by Vector

10.2.4 North America: Gene Therapy Market Breakdown, by Indications

10.2.4.1 North America: Gene Therapy Market – Revenue and Forecast Analysis – by Indications

10.2.5 North America: Gene Therapy Market Breakdown, by Delivery Mode

10.2.5.1 North America: Gene Therapy Market – Revenue and Forecast Analysis – by Delivery Mode

10.2.6 North America: Gene Therapy Market – Revenue and Forecast Analysis – by Country

10.2.6.1 North America: Gene Therapy Market – Revenue and Forecast Analysis – by Country

10.2.6.2 United States: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.2.6.2.1 United States: Gene Therapy Market Breakdown, by Vector

10.2.6.2.2 United States: Gene Therapy Market Breakdown, by Indications

10.2.6.2.3 United States: Gene Therapy Market Breakdown, by Delivery Mode

10.2.6.3 Canada: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.2.6.3.1 Canada: Gene Therapy Market Breakdown, by Vector

10.2.6.3.2 Canada: Gene Therapy Market Breakdown, by Indications

10.2.6.3.3 Canada: Gene Therapy Market Breakdown, by Delivery Mode

10.2.6.4 Mexico: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.2.6.4.1 Mexico: Gene Therapy Market Breakdown, by Vector

10.2.6.4.2 Mexico: Gene Therapy Market Breakdown, by Indications

10.2.6.4.3 Mexico: Gene Therapy Market Breakdown, by Delivery Mode

10.3 Europe

10.3.1 Europe Gene Therapy Market Overview

10.3.2 Europe: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)

10.3.3 Europe: Gene Therapy Market Breakdown, by Vector

10.3.3.1 Europe: Gene Therapy Market – Revenue and Forecast Analysis – by Vector

10.3.4 Europe: Gene Therapy Market Breakdown, by Indications

10.3.4.1 Europe: Gene Therapy Market – Revenue and Forecast Analysis – by Indications

10.3.5 Europe: Gene Therapy Market Breakdown, by Delivery Mode

10.3.5.1 Europe: Gene Therapy Market – Revenue and Forecast Analysis – by Delivery Mode

10.3.6 Europe: Gene Therapy Market – Revenue and Forecast Analysis – by Country

10.3.6.1 Europe: Gene Therapy Market – Revenue and Forecast Analysis – by Country

10.3.6.2 United Kingdom: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.3.6.2.1 United Kingdom: Gene Therapy Market Breakdown, by Vector

10.3.6.2.2 United Kingdom: Gene Therapy Market Breakdown, by Indications

10.3.6.2.3 United Kingdom: Gene Therapy Market Breakdown, by Delivery Mode

10.3.6.3 Germany: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.3.6.3.1 Germany: Gene Therapy Market Breakdown, by Vector

10.3.6.3.2 Germany: Gene Therapy Market Breakdown, by Indications

10.3.6.3.3 Germany: Gene Therapy Market Breakdown, by Delivery Mode

10.3.6.4 France: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.3.6.4.1 France: Gene Therapy Market Breakdown, by Vector

10.3.6.4.2 France: Gene Therapy Market Breakdown, by Indications

10.3.6.4.3 France: Gene Therapy Market Breakdown, by Delivery Mode

10.3.6.5 Spain: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.3.6.5.1 Spain: Gene Therapy Market Breakdown, by Vector

10.3.6.5.2 Spain: Gene Therapy Market Breakdown, by Indications

10.3.6.5.3 Spain: Gene Therapy Market Breakdown, by Delivery Mode

10.3.6.6 Italy: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.3.6.6.1 Italy: Gene Therapy Market Breakdown, by Vector

10.3.6.6.2 Italy: Gene Therapy Market Breakdown, by Indications

10.3.6.6.3 Italy: Gene Therapy Market Breakdown, by Delivery Mode

10.3.6.7 Rest of Europe: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.3.6.7.1 Rest of Europe: Gene Therapy Market Breakdown, by Vector

10.3.6.7.2 Rest of Europe: Gene Therapy Market Breakdown, by Indications

10.3.6.7.3 Rest of Europe: Gene Therapy Market Breakdown, by Delivery Mode

10.4 Asia Pacific

10.4.1 Asia Pacific Gene Therapy Market Overview

10.4.2 Asia Pacific: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)

10.4.3 Asia Pacific: Gene Therapy Market Breakdown, by Vector

10.4.3.1 Asia Pacific: Gene Therapy Market – Revenue and Forecast Analysis – by Vector

10.4.4 Asia Pacific: Gene Therapy Market Breakdown, by Indications

10.4.4.1 Asia Pacific: Gene Therapy Market – Revenue and Forecast Analysis – by Indications

10.4.5 Asia Pacific: Gene Therapy Market Breakdown, by Delivery Mode

10.4.5.1 Asia Pacific: Gene Therapy Market – Revenue and Forecast Analysis – by Delivery Mode

10.4.6 Asia Pacific: Gene Therapy Market – Revenue and Forecast Analysis – by Country

10.4.6.1 Asia Pacific: Gene Therapy Market – Revenue and Forecast Analysis – by Country

10.4.6.2 China: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.4.6.2.1 China: Gene Therapy Market Breakdown, by Vector

10.4.6.2.2 China: Gene Therapy Market Breakdown, by Indications

10.4.6.2.3 China: Gene Therapy Market Breakdown, by Delivery Mode

10.4.6.3 Japan: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.4.6.3.1 Japan: Gene Therapy Market Breakdown, by Vector

10.4.6.3.2 Japan: Gene Therapy Market Breakdown, by Indications

10.4.6.3.3 Japan: Gene Therapy Market Breakdown, by Delivery Mode

10.4.6.4 India: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.4.6.4.1 India: Gene Therapy Market Breakdown, by Vector

10.4.6.4.2 India: Gene Therapy Market Breakdown, by Indications

10.4.6.4.3 India: Gene Therapy Market Breakdown, by Delivery Mode

10.4.6.5 Australia: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.4.6.5.1 Australia: Gene Therapy Market Breakdown, by Vector

10.4.6.5.2 Australia: Gene Therapy Market Breakdown, by Indications

10.4.6.5.3 Australia: Gene Therapy Market Breakdown, by Delivery Mode

10.4.6.6 South Korea: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.4.6.6.1 South Korea: Gene Therapy Market Breakdown, by Vector

10.4.6.6.2 South Korea: Gene Therapy Market Breakdown, by Indications

10.4.6.6.3 South Korea: Gene Therapy Market Breakdown, by Delivery Mode

10.4.6.7 Rest of APAC: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.4.6.7.1 Rest of APAC: Gene Therapy Market Breakdown, by Vector

10.4.6.7.2 Rest of APAC: Gene Therapy Market Breakdown, by Indications

10.4.6.7.3 Rest of APAC: Gene Therapy Market Breakdown, by Delivery Mode

10.5 Middle East and Africa

10.5.1 Middle East and Africa Gene Therapy Market Overview

10.5.2 Middle East and Africa: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)

10.5.3 Middle East and Africa: Gene Therapy Market Breakdown, by Vector

10.5.3.1 Middle East and Africa: Gene Therapy Market – Revenue and Forecast Analysis – by Vector

10.5.4 Middle East and Africa: Gene Therapy Market Breakdown, by Indications

10.5.4.1 Middle East and Africa: Gene Therapy Market – Revenue and Forecast Analysis – by Indications

10.5.5 Middle East and Africa: Gene Therapy Market Breakdown, by Delivery Mode

10.5.5.1 Middle East and Africa: Gene Therapy Market – Revenue and Forecast Analysis – by Delivery Mode

10.5.6 Middle East and Africa: Gene Therapy Market – Revenue and Forecast Analysis – by Country

10.5.6.1 Middle East and Africa: Gene Therapy Market – Revenue and Forecast Analysis – by Country

10.5.6.2 Saudi Arabia: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.5.6.2.1 Saudi Arabia: Gene Therapy Market Breakdown, by Vector

10.5.6.2.2 Saudi Arabia: Gene Therapy Market Breakdown, by Indications

10.5.6.2.3 Saudi Arabia: Gene Therapy Market Breakdown, by Delivery Mode

10.5.6.3 South Africa: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.5.6.3.1 South Africa: Gene Therapy Market Breakdown, by Vector

10.5.6.3.2 South Africa: Gene Therapy Market Breakdown, by Indications

10.5.6.3.3 South Africa: Gene Therapy Market Breakdown, by Delivery Mode

10.5.6.4 United Arab Emirates: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.5.6.4.1 United Arab Emirates: Gene Therapy Market Breakdown, by Vector

10.5.6.4.2 United Arab Emirates: Gene Therapy Market Breakdown, by Indications

10.5.6.4.3 United Arab Emirates: Gene Therapy Market Breakdown, by Delivery Mode

10.5.6.5 Rest of Middle East and Africa: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.5.6.5.1 Rest of Middle East and Africa: Gene Therapy Market Breakdown, by Vector

10.5.6.5.2 Rest of Middle East and Africa: Gene Therapy Market Breakdown, by Indications

10.5.6.5.3 Rest of Middle East and Africa: Gene Therapy Market Breakdown, by Delivery Mode

10.6 South and Central America

10.6.1 South and Central America Gene Therapy Market Overview

10.6.2 South and Central America: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)

10.6.3 South and Central America: Gene Therapy Market Breakdown, by Vector

10.6.3.1 South and Central America: Gene Therapy Market – Revenue and Forecast Analysis – by Vector

10.6.4 South and Central America: Gene Therapy Market Breakdown, by Indications

10.6.4.1 South and Central America: Gene Therapy Market – Revenue and Forecast Analysis – by Indications

10.6.5 South and Central America: Gene Therapy Market Breakdown, by Delivery Mode

10.6.5.1 South and Central America: Gene Therapy Market – Revenue and Forecast Analysis – by Delivery Mode

10.6.6 South and Central America: Gene Therapy Market – Revenue and Forecast Analysis – by Country

10.6.6.1 South and Central America: Gene Therapy Market – Revenue and Forecast Analysis – by Country

10.6.6.2 Brazil: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.6.6.2.1 Brazil: Gene Therapy Market Breakdown, by Vector

10.6.6.2.2 Brazil: Gene Therapy Market Breakdown, by Indications

10.6.6.2.3 Brazil: Gene Therapy Market Breakdown, by Delivery Mode

10.6.6.3 Argentina: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.6.6.3.1 Argentina: Gene Therapy Market Breakdown, by Vector

10.6.6.3.2 Argentina: Gene Therapy Market Breakdown, by Indications

10.6.6.3.3 Argentina: Gene Therapy Market Breakdown, by Delivery Mode

10.6.6.4 Rest of South and Central America: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.6.6.4.1 Rest of South and Central America: Gene Therapy Market Breakdown, by Vector

10.6.6.4.2 Rest of South and Central America: Gene Therapy Market Breakdown, by Indications

10.6.6.4.3 Rest of South and Central America: Gene Therapy Market Breakdown, by Delivery Mode

11. Competitive Landscape

11.1 Heat Map Analysis by Key Players

11.2 Company Market Share Analysis, 2024

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Merger and Acquisition

13. Company Profiles

13.1 Novartis AG

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Astellas Pharma Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Bristol-Myers Squibb Co

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Bluebird Bio Inc

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Catalent Inc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Sanofi SA

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Daiichi Sankyo Co Ltd

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 CSL Behring LLC

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 BioMarin Pharmaceutical Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Vertex Pharmaceuticals Inc

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 Glossary of Terms, Gene Therapy Market

14.2 About The Insight Partners

List of Tables

Table 1. Gene Therapy Market Segmentation

Table 2. Gene Therapy Market – Revenue, 2021–2024 (US$ Million)

Table 3. Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million)

Table 4. Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 5. Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 6. Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 7. Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 8. Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 9. Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 10. North America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 11. North America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 12. North America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 13. North America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 14. North America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 15. North America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 16. North America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 17. North America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 18. United States: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 19. United States: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 20. United States: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 21. United States: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 22. United States: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 23. United States: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 24. Canada: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 25. Canada: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 26. Canada: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 27. Canada: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 28. Canada: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 29. Canada: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 30. Mexico: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 31. Mexico: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 32. Mexico: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 33. Mexico: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 34. Mexico: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 35. Mexico: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 36. Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 37. Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 38. Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 39. Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 40. Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 41. Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 42. Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 43. Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 44. United Kingdom: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 45. United Kingdom: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 46. United Kingdom: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 47. United Kingdom: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 48. United Kingdom: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 49. United Kingdom: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 50. Germany: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 51. Germany: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 52. Germany: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 53. Germany: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 54. Germany: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 55. Germany: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 56. France: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 57. France: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 58. France: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 59. France: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 60. France: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 61. France: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 62. Spain: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 63. Spain: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 64. Spain: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 65. Spain: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 66. Spain: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 67. Spain: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 68. Italy: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 69. Italy: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 70. Italy: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 71. Italy: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 72. Italy: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 73. Italy: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 74. Rest of Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 75. Rest of Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 76. Rest of Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 77. Rest of Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 78. Rest of Europe: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 79. Rest of Europe: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 80. Asia Pacific: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 81. Asia Pacific: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 82. Asia Pacific: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 83. Asia Pacific: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 84. Asia Pacific: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 85. Asia Pacific: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 86. Asia Pacific: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 87. Asia Pacific: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 88. China: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 89. China: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 90. China: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 91. China: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 92. China: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 93. China: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 94. Japan: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 95. Japan: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 96. Japan: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 97. Japan: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 98. Japan: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 99. Japan: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 100. India: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 101. India: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 102. India: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 103. India: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 104. India: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 105. India: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 106. Australia: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 107. Australia: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 108. Australia: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 109. Australia: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 110. Australia: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 111. Australia: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 112. South Korea: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 113. South Korea: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 114. South Korea: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 115. South Korea: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 116. South Korea: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 117. South Korea: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 118. Rest of APAC: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 119. Rest of APAC: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 120. Rest of APAC: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 121. Rest of APAC: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 122. Rest of APAC: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 123. Rest of APAC: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 124. Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 125. Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 126. Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 127. Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 128. Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 129. Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 130. Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 131. Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 132. Saudi Arabia: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 133. Saudi Arabia: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 134. Saudi Arabia: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 135. Saudi Arabia: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 136. Saudi Arabia: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 137. Saudi Arabia: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 138. South Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 139. South Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 140. South Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 141. South Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 142. South Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 143. South Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 144. United Arab Emirates: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 145. United Arab Emirates: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 146. United Arab Emirates: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 147. United Arab Emirates: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 148. United Arab Emirates: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 149. United Arab Emirates: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 150. Rest of Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 151. Rest of Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 152. Rest of Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 153. Rest of Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 154. Rest of Middle East and Africa: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 155. Rest of Middle East and Africa: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 156. South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 157. South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 158. South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 159. South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 160. South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 161. South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 162. South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Country

Table 163. South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Country

Table 164. Brazil: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 165. Brazil: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 166. Brazil: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 167. Brazil: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 168. Brazil: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 169. Brazil: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 170. Argentina: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 171. Argentina: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 172. Argentina: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 173. Argentina: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 174. Argentina: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 175. Argentina: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 176. Rest of South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Vector

Table 177. Rest of South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Vector

Table 178. Rest of South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 179. Rest of South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 180. Rest of South and Central America: Gene Therapy Market – Revenue, 2021–2024 (US$ Million) – by Delivery Mode

Table 181. Rest of South and Central America: Gene Therapy Market – Revenue Forecast, 2025–2031 (US$ Million) – by Delivery Mode

Table 182. Heat Map Analysis by Key Players

List of Figures

Figure 1. Gene Therapy Market Segmentation, by Geography

Figure 2. PEST Analysis

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Gene Therapy Market Revenue (US$ Million), 2021–2031

Figure 5. Gene Therapy Market Share (%) – by Vector (2024 and 2031)

Figure 6. Non-Viral Vectors: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7. Viral Vectors: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8. Gene Therapy Market Share (%) – by Indications (2024 and 2031)

Figure 9. Neurological Diseases: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10. Cancer: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11. Duchenne Muscular Dystrophy: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12. Hepatological Diseases: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13. Other Indications: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14. Gene Therapy Market Share (%) – by Delivery Mode (2024 and 2031)

Figure 15. In-Vivo: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16. Ex-Vivo: Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17. Gene Therapy Market Breakdown by Region, 2024 and 2031 (%)

Figure 18. North America: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)

Figure 19. North America: Gene Therapy Market Breakdown, by Vector (2024 and 2031)

Figure 20. North America: Gene Therapy Market Breakdown, by Indications (2024 and 2031)

Figure 21. North America: Gene Therapy Market Breakdown, by Delivery Mode (2024 and 2031)

Figure 22. North America: Gene Therapy Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 23. United States: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 24. Canada: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 25. Mexico: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 26. Europe: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)

Figure 27. Europe: Gene Therapy Market Breakdown, by Vector (2024 and 2031)

Figure 28. Europe: Gene Therapy Market Breakdown, by Indications (2024 and 2031)

Figure 29. Europe: Gene Therapy Market Breakdown, by Delivery Mode (2024 and 2031)

Figure 30. Europe: Gene Therapy Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 31. United Kingdom: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 32. Germany: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 33. France: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 34. Spain: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 35. Italy: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 36. Rest of Europe: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 37. Asia Pacific: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)

Figure 38. Asia Pacific: Gene Therapy Market Breakdown, by Vector (2024 and 2031)

Figure 39. Asia Pacific: Gene Therapy Market Breakdown, by Indications (2024 and 2031)

Figure 40. Asia Pacific: Gene Therapy Market Breakdown, by Delivery Mode (2024 and 2031)

Figure 41. Asia Pacific: Gene Therapy Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 42. China: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 43. Japan: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 44. India: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 45. Australia: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 46. South Korea: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 47. Rest of APAC: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 48. Middle East and Africa: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)

Figure 49. Middle East and Africa: Gene Therapy Market Breakdown, by Vector (2024 and 2031)

Figure 50. Middle East and Africa: Gene Therapy Market Breakdown, by Indications (2024 and 2031)

Figure 51. Middle East and Africa: Gene Therapy Market Breakdown, by Delivery Mode (2024 and 2031)

Figure 52. Middle East and Africa: Gene Therapy Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 53. Saudi Arabia: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 54. South Africa: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 55. United Arab Emirates: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 56. Rest of Middle East and Africa: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 57. South and Central America: Gene Therapy Market – Revenue, 2021–2031 (US$ Million)

Figure 58. South and Central America: Gene Therapy Market Breakdown, by Vector (2024 and 2031)

Figure 59. South and Central America: Gene Therapy Market Breakdown, by Indications (2024 and 2031)

Figure 60. South and Central America: Gene Therapy Market Breakdown, by Delivery Mode (2024 and 2031)

Figure 61. South and Central America: Gene Therapy Market Breakdown, by Key Countries, 2024 and 2031 (%)

Figure 62. Brazil: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 63. Argentina: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 64. Rest of South and Central America: Gene Therapy Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 65. Company Market Share Analysis, 2024

Your Key Concerns Addressed - Question & Answer
Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.

Is there support available if I can't access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Cover Image

Oct 2025

Urokinase API and Finished Dosage Forms Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Active Pharmaceutical Ingredient and Finished Dosage Forms), Manufacturing Process (Urine-derived, Cell Culture-based, and Recombinant Technology), Indication (Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), Catheter Occlusion, Myocardial Infarction (Heart Attack), Peripheral Arterial Occlusive Diseases, and Others), Distribution Channel (Hospital Pharmacies, Retail and Drug Stores, Direct Sales (API and FDF), and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)

[read more] GET SAMPLE   
Cover Image

Oct 2025

Aesthetic Fillers and Exosomes Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate (PMMA), Fat Fillers, and Others) and Exosome-Based Aesthetic Products (Human-derived, Animal-derived, and Plant-derived)], Route of Administration [Injectable, Topical (Serum, Cream, Mask, and Others)], Application (Skin Rejuvenation, Wrinkle Reduction and Fine Line Correction, Facial Contouring, Lip Augmentation, Scar and Pigmentation, Post-procedure Recovery, Hair Restoration, and Others), End User (Hospitals, Dermatology Clinics, Medical Spas, and Others), and Geography (North America, Europe, and Middle East)

[read more] GET SAMPLE   
Cover Image

Oct 2025

Veterinary Diagnostics Products Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Kits and Reagents [ELISA Test Kits, Antibodies Test Kits, Polymerase Chain Reaction (PCR) Test Kits, Hematology Test Kits, Biochemistry Test Kits, Immunoassay Reagents, and Others]and Analyzers [Biochemistry Analyzers, Hematology Analyzers, Immunoassay Analyzers, PCR Analyzers, and Others]), Animal Type (Companion Animal [Dogs, Cats, Horses, and Others] and Livestock Animal [Cattles, Pigs, Poultry, and Others]), Application (Infectious Diseases [Rabies, Avian Influenza, Leishmania, Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection, and Others] and Non-Infectious Diseases [Pneumonia, Gastritis, Bronchitis, and Others]), End User (Public Healthcare Facilities and Private Healthcare Facilities), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)

[read more] GET SAMPLE   
Cover Image

Oct 2025

High Potent Pharmaceuticals Product Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [APIs (Synthetic High Potency Active Pharmaceutical Ingredients and Biotech High Potency Active Pharmaceutical Ingredients) and Finished Dosage Forms (Tablets, Capsules, Injectables, and Others)], Drug Type (Innovative Drugs and Generic Drugs), Indication (Oncology, Hormonal Disorders, Autoimmune or Immunology, Infectious Diseases, CNS Disorders, Cardiovascular Diseases, and Others), Manufacturing Type (In-House Manufacturing and Outsourced (Contract Manufacturing)), Distribution Channel (Hospital Pharmacies, Retail and Drug Stores, Online Pharmacies, and Others)

[read more] GET SAMPLE   
Cover Image

Oct 2025

Delay Condoms Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Condoms and Dental Dams), Category (Flavored and Plain), Material (Latex and Non-Latex), Distribution Channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retails and Others), and Geography

[read more] GET SAMPLE   
Cover Image

Oct 2025

Wheelchair and Mobility Aids Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Wheelchairs (Manual, Powered, Power Assisted, and Accessories), Mobility Scooters, Walking Aids, and Others), Application (Neurologically Impaired, Handicap Patients, and Other Applications), End User (Homecare, Hospitals and Clinics, Rehabilitation Centers, and Others), and Distribution Channel (Online and Offline)

[read more] GET SAMPLE   
Cover Image

Oct 2025

Cystoscopy and Ureteroscopy Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [Cystoscope (Rigid and Flexible), and Ureteroscope (Flexible and Semi-Flexible)], Procedure (Stone Management, Bladder Cancer, Benign Prostatic Hyperplasia, and Others), Technology (Fiberoptic and Video), Usage Type (Reusable and Single Use), End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South and Central America)

[read more] GET SAMPLE   
Cover Image

Oct 2025

Cancer Drugs Market

Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, and Other Therapy Types), By Indications (Blood Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Ducts Cancer, Thyroid Cancer, and Other Indications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores), and Geography

[read more] GET SAMPLE